If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of ...
Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...
The Mark Foundation for Cancer Research is proud to announce the recipients of the 2025 Emerging Leader Awards, recognizing five outstanding early-career scientists dedicated to revolutionizing cancer ...